This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Source: www.marketwatch.com · Section: business-tech · Bias: Center · Published: Tue, 22 Sep 2026 20:27:00 GMT

Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock soared.

Read the full article at www.marketwatch.com →

The same story across the political spectrum (4 sources)

Center: Patients sue GLP-1 makers over sudden loss of vision — thehill.com
Center: JB Pritzker Says He Used GLP-1s to Lose 80 Pounds — www.nytimes.com
Center: Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year — www.gizmodo.com
Right: JB Pritzker Says He Lost 80 Lbs. on GLP-1 as Taxpayers Cover State Workers' Access — www.breitbart.com

← Back to FlashTopics.com